GC91380 N6F11 N6F11 is a novel, selective and potent inducer of iron death with anticancer and antitumour activity that promotes GPX4 degradation by binding to TRIM25 in cancer cells
GERD, gastro-esophageal reflux disease
Vitamin D deficiency and the COVID-19 pandemic
Antibodies against phospho-IR/IGF1R (#3024, 1:500), IGF1R (#3027, 1:500), phospho-Shc (Y239/240) (#2434, 1:500), Shc (#2432, 1:500), phospho-Gab-1 (Y627) (#3233, 1:500), Gab-1 (#3232, 1:500), phospho-ERK1/2 (T202/Y204) (#9101, 1:1,000), ERK1/2 (#9102, 1:1,000), phospho-Akt (S473) (#9271, 1:1,000), Akt (#4685, 1:1,000), phospho-S6K1(T389) (#9205, 1:1,000), phospho-S6 (S235/236) (#2211, 1:2,000), S6 (#2317, 1:500), GAPDH (#5174, 1:1,000) were purchased from Cell Signaling Technologies